https://parkinsonsnewstoday.com/news/first-healthy-volunteer-dosed-study-her-096-parkinsons/
A clinical study testing Herantis Pharma’s HER-096, a treatment candidate for Parkinson’s disease, has dosed its first healthy volunteer.
Create an account
or login to join the discussion